Platform Offers Online API Trading
Kemiex trading network is designed to increase safety in the sourcing of APIs and additives.
Kemiex, an online platform developed in 2017 to improve the way APIs, additives, and excipients are traded for human and animal health and nutrition industries, is open for registration; trading will be launched later in 2018.
The platform connects users to a global network of qualified counterparties, enabling them to minimize transaction lead times, achieve more competitive prices, and to stay in control of the trading activity, the platform developers report.
The platform is accessible 24/7 and covers the trade functions including quoting a product request, private negotiations, trade execution, document management, and reporting and pricing intelligence.
The platform, designed to help companies identify reliable and compliant counterparties around the world, is made for traders, buyers, and sellers that meet predefined quality assurance and financial due diligence criteria. Typical buyers are traders, manufacturers of finished products, and premixtures. Sellers are traders, distributors, and selected European ingredient manufacturers, the developers report.
The development team is supported by advisors from pharma, insurance, IT, and financial services.
Source: Kemiex
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
